Pharmaceutical Name: Imidocarb Dipropionate for Injection Features & Benefits: Two treatments two weeks apart Simplifies treatment regimen Injectable administration keeps the treatment under your control. Eliminates the issue of treatment compliance. Intramuscular or subcutaneous administration Provides more versatility Low volume dose treatment (3mg/lb), 100 lbs dog requires only 2.5 mL of IMIZOL per injection. Makes it cost effective and practical Indications: IMIZOL is a sterile solution containing imidocarb dipropionate for the treatment of dogs with clinical signs of babesiosis and/or demonstrated Babesia organisms in the blood. Canine babesiosis is a disease caused by tick-borne hematozoan organisms of the genus Babesia. IMIZOL is the only drug labeled for the treatment of canine babesiosis or of Babesia infected dogs. Dosage: For further information including dose rate and complete directions and warnings, please see the Product Label. Imizol is a registered trademark of Schering-Plough Animal Health Corporation. | 
